A flexible technology for modified release of drugs: Multi layered tablets

Journal of Controlled Release

Volumn 97, Issue 3, 2004, Pages 393-405

  Abdul, Shajahan ^a   Poddar, S S ^a  

^a PRIN K M KUNDNANI COLLEGE OF PHARMACY   (India)

Author keywords

Bimodal release; Layered matrix system; Linear release; Multi layered tablets; Time programmed release

Indexed keywords

CONTROLLED DRUG DELIVERY; ORGANIC POLYMERS; PARAMETER ESTIMATION; SYSTEMS ANALYSIS;

CONTROLLED MATRIX DEVICES; FLEXIBLE TECHNOLOGY;

DRUG DOSAGE;

CONTROLLED DRUG RELEASE; DIFFUSION; DRUG FORMULATION; DRUG RELEASE; HYDROPHILICITY; HYDROPHOBICITY; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY; TABLET;

DELAYED-ACTION PREPARATIONS; TABLETS, ENTERIC-COATED; TECHNOLOGY, PHARMACEUTICAL;

EID: 3042686674     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.03.034     Document Type: Review

References (94)

1. Chien Y.W. Fundamentals of controlled-release of drug administration. Swarbrick J. Novel Drug Delivery System. 1982;465-574 Marcel Dekker, New York
2. Buri P., Puisicux F., Doelker E., Benoit J.P. Formes Pharma centiques Nouvelles, Ed. Technique et Documentation. 1985;Lavoisier, Paris
3. Wilding I.R., Coupe A.J., Davis S.S. The role of gamma scintigraphy in oral drug delivery. Adv. Drug Deliv. Rev. 7:1991;87-117
4. Lee L. Diffusion-controlled matrix systems. Kydonieus A. Treatise on Controlled Drug Delivery. 1992;155-198 Marcel Dekker, New York
5. Peppas N.A. Hydrogels in Medicine and Pharmacy. vols. I, II and III:1988;CRC Press, Boca Raton, FL
6. Narasimhan B., Langer R. Zero-order release of micro and macromolecules from polymeric devices: the role of the burst effect. J. Control. Release. 47:1997;13-20
7. Conte U., Maggi L. A flexible technology for the linear, pulsatile and delayed release of drugs, allowing for easy accommodation of difficult in vitro targets. J. Control. Release. 64:2000;263-268
8. Nelson K.G., Smith S.J., Bennett R.M. Constant-release diffusion systems: rate control by means of geometric configuration. Lee P.I., Good W.R. Controlled-Released Technology: Pharmaceutical Applications. Acs Symposium Series. vol. 348:1987;324-340 American Chemical Society, Washington, DC
9. Peppas N.A., Sahlin J.J. A simple equation for the description of solute release: III. Coupling of diffusion and relaxation. Int. J. Pharm. 57:1989;169-172
10. Buri P., Doelker E. Formulation des comprimes a liberation prolengee: II. Matrices hydrophiles. Pharm. Acta Helv. 7-8:1980;189-197
11. Lee P.I. Kinetics of drug release from the hydrogel matrices. J. Control. Release. 2:1985;277-288
12. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J. Pharm. Sci. 50:1961;874-875
13. Ritger P.L., Peppas N.A. A simple equation for the description of solute release: I. Fickian and non-Fickian release from swellable devices in the form of slabs, spheres, cylinders or discs. J. Control. Release. 5:1987;23-36
14. Ritger P.L., Peppas N.A. A simple equation for the description of solute release: II. Fickian and anomalous release from swellable devices. J. Control. Release. 5:1987;37-42
15. Harland R.S., Gazzaniga A., Sangalli M.E., Colombo P., Peppas N.A. Drug/Polymer matrix swelling and dissolution. Pharm. Res. 5:1988;488-494
16. Gander B., Gurny R., Doelker E., Peppas N.A. Crosslinked poly (alkylene oxides) for the preparation of controlled-release micro matrices. J. Control. Release. 5:1987;271-283
17. Ford J.L., Rubinstein M.H., McCaul F., Hogan J.E., Edgar Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethylcellullose matrix tablets. Int. J. Pharm. 40:1987;223-234
18. Alderman D. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int. J. Pharm. Prod. Manuf. 5:1984;1-9
19. J.L. Salomon, P. Vaugnat, E. Doelker, P. Buri, Importance de la technologie et de la formulation pour le mechanisme de liberation du chlorure de potassium contenu dans des matrices hydrophiles, Pharm Acta. Helv., 3 (1079) 86-89.
20. Cobby J., Mayersonhn M., Walker G.C. Influence of shape factors on kinetics of drug release from matrix tablets: I. Theoretical. J. Pharm. Sci. 63:1974;725-731
21. Cobby J., Mayersonhn M., Walker G.C. Influence of shape factors on kinetics of drug release from matrix tablets: II. Experimental. J. Pharm. Sci. 63:1974;732-737
22. Hildgen D., McMullen J.N. A new gradient matrix: formulation and characterization. J. Control. Release. 34:1995;263-271
23. Danckwerts M.P. Development of a zero-order release oral compressed tablet with potential for commercial tabletting production. Int. J. Pharm. 112:1994;34-45
24. Kim C. Compressed Donut-shaped tablets with zero-order release kinetics. Pharm. Res. 12:1994;1045-1048
25. Benkorah A.Y., McMullen J.N. Biconcave coated, centrally perforated tablets for oral controlled drug delivery. J. Control. Release. 32:1994;155-160
26. Samuelov Y., Donbrow M., Friedman M. Sustained-release of drugs from Ethyl cellulose-polyethylene glycol films and kinetics of drug release. J. Pharm. Sci. 68:1979;325-329
27. Scott D.C., Hollenbeck R.G. Design and manufacture of zero-order sustained-release pellet dosage from through non uniform drug distribution in a diffusional matrix. Pharm. Res. 8:1991;156-161
28. Brooke D., Walshkuhn R.J. Zero-order drug delivery system: theory and preliminary testing. J. Pharm. Sci. 66:1977;159-162
29. Lipper R.A., Higuchi W.I. Analysis of theoretical behaviour of proposed zero-order drug delivery system. J. Pharm. Sci. 66:1977;163-164
30. Hsiesh D.S.T., Rhine W.D., Langer R. Zero-order controlled-release polymer matrices from micro and macro molecules. J. Pharm. Sci. 72:1983;17-22
31. Zin El-Din E., El-Shaboury M.H., El-Aleem H.A. Effect of tablet shape on the in vitro and in vivo availability of directly compressed non-disintegrating tablets. Pharm. Ind. 51:1989;694-696
32. Shah A.C., Britten N.J. Novel divisible design for sustained-release formulations. J. Control. Release. 14:1990;179-185
33. Bodmeier R., Paeratakul O. Drug release form laminated polymeric films prepared from aqueous latexes. J. Pharm. Sci. 79:1990;32-36
34. Colombo P., Conte U., Gazzaniga A., Maggi L., Sangalli M.E., Peppas N.A., LaManna A. Drug release modulation by physical restriction of matrix swelling. Int. J. Pharm. 63:1990;43-48
35. Conte U., Maggi L., Colombo P., La Manna A. Multi-layered hydrophilic matrices as constant release devices (Geomatrix™ Systems*). J. Control. Release. 26:1993;39-47
36. Conte U., Maggi L. Multilayer tablets as drug delivery devices. Pharm. Technol. 22(3):1998;174-182
37. Colombo P., Gazzaniga A., Caramella C., Conte U., La Manna A. In vitro progragmmable zero-order release drug delivery systems. Acta Pharm. Technol. 33:1987;15-20
38. La Manna A., Conte U., Colombo P. Physical restriction in swellable matrices as modulator of drug release. Eurobiomat Workshop on "Synthetic Polymer as Drug carriers. Interaction with blood." Pallanza, Italy, 21-24 April:1991
39. U. Conte, A. La Manna, P. Colombo, System for the controlled rate release of active substances, U.S. Patent 4, 839, 177, June 13, 1989.
40. Conte U., Colombo P., Maggi L., La Manna A. Compressed barrier layers for constant drug release in swellable matrix tablets. STP Pharma Sci. 4:1994;107-113
41. U. Conte, A. La Manna, P. Colombo, Tablets with controlled rate release of active substances, U.S. Patent 5, 422, 123 June 06, 1995.
42. Shepard T., Zimmer R., Maggi L., Conte U. Successful application of in vitro/in vivo correlation(IVIVC) for optimization of a Geomatrix® delivery systems for an oral antibiotic. Proceedings of the AAPS 10th Annual Meeting, November 5-9, 1995, Miami beach, FL, USA, OR. Pharm. Res. vol. 12 (9):1995;S-376. PPDM 8200
43. Rochdi M., Grenier P., Bethke P., Rehak J., Zimmer R. Successful reformulation based on in vitro/in vivo correlation(IVIVC) for a Verapamil Geomatrix® bio equivalent to Calan® Proceedings of the AAPS 11th Annual Meeting, October 26-31, 1996, Seattle, USA, OR. Pharm. Res. vol. 13 (9):1996;S-471. PPDM 8316
44. Wilding I.R., Davis S.S., Sparrow R.A., Ziemniak J.A., Heald D.L. Pharmacoscintigraphic evaluation of modified release (Geomatrix®) Diltiazem formulation. J. Control. Release. 33:1995;89-97
45. Conte U., Maggi L. Modulation of the dissolution profiles from Geomatrix® multi-layer matrix tablets containing drugs of different solubility. Biomaterials. 17:1996;889-896
46. Conte U., Maggi L., Giunchedi P., Sangalli M.E., La Manna A. Multil-layer hydrophilic matrix tablets as controlled delivery systems. Proceedings of the Second European Symposium on Controlled Drug Delivery, April 1-3, 1992, Noordwijk. 1992;117-120 Aan Zee, The Netherlands
47. Conte U., Colombo P., Magi L., La Manna A. Compressed barrier layers for constant drug release in swellable matrix tablets. Proceedings of 6th International Conference on Pharmaceutiacal Technology, June 2-4, 1992, Paris, France. 1992;102-111. Vol. II
48. Qiu Y., Chidambaram N., Flood K. Design and evaluation of layered diffusion matrices for zero-order sustained-release. J. Control. Release. 51:1998;123-130
49. Chidambaram N., Porter W., Flood K., Qiu Y. Formulation and characterization of new layered diffusional matrices for zero-order systained-release. J. Control. Release. 52:1998;149-158
50. Krishnaiah Y.S.R., Karthikeyan R.S., GouriSankar V., Satyanarayana V. Three-layer guar gum matrix formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride. J. Control. Release. 81:2002;45-56
51. Krishnaiah Y.S.R., Karthikeyan R.S., Bhaskar P., Satyanarayana V. Bioavailability studies on guar gum-based three-layer matrix tablets of trimetazidine dihydrochloride in human volunteer. J. Control. Release. 83:2002;231-239
52. Maggi L., Morgenthaler S., Zimmer R., Shepard T., Conte U. Human evaluation of Quick/Slow drug delivery technology: a new therapeutic approach. Proceedings of the 22nd International Symposium on Controlled Release of Bioactive Materails, Seattle, USA, July 31-August 2. 1992;208-209
53. Maggi L., Shepard T., Rochdi M., Grenier P., Halbeisen S., Zimmer R., Conte U. A simulation approach for efficient development of a naproxen Geomatrix Quick/Slow formulation. Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials, Stockholm, Sweden, June 15-19. 1997;327-328
54. U. Conte, A. La Manna, L. Maggi, Pharmaceutical tablet capable of liberating one or more drugs at different release rates, PCT Int. Appl. WO 94/06416, 31 March 1994.
55. Reinberg A.E. Concepts in chronopharmacology. Annu. Rev. Pharmacol. Toxicol. 32:1992;51-66
56. Lemmer N. The clinical relevance of chronopharmacology in therapeutics. Pharmacol. Res. 33:1996;107-115
57. Smlensky M.H., D'alanzo G.E. Medical chronobiology: concepts and applications. Am. Rev. Respir. Dis. 147:1993;s2-s19
58. D'Emanuele A. Responsive polymeric drug delivery. Clin. Pharmcokinet. 31:1996;241-245
59. Yoshida R., Sakai K., Okano T., Sakurai Y. Pulsatile drug delivery systems using hydrogels. Adv. Drug Deliv. Rev. 11:1993;85-108
60. Lin S.Y., Lin Y.Y., Chen K.S. Permeation behaviour of salbutamol sulfate through hydrophilic and hydrophobic membranes embedded by thermo-responsive cholesteryl oleyl carbonate. Pharm. Res. 13:1996;914-919
61. Lin S.Y., Chen K.S., Lin Y.Y. Artifical thermo-responsive membrane able to control on-off switching drug release through nude mice skin without on interference from skin penetrating enhancers. J. Bioact. Compat. Polym. 15:2000;170-178
62. Pozzi F., Furlani P., Gazzaniga A., Davis S.S., Wilding I.R. The time clock system: a new oral dosage from for fast complete release of drug after a predetermined lagtime. Int. J. Pharm. 31:1994;99-108
63. Narisawa S., Nagata M., Danyoshi C., Yoshino H., Murata K., Hirakawa Y., Noda K. An oranic acid induced sigmoidal release systems for oral controlled -release preparations. Pharm. Res. 11(1):1994;111-116
64. Conte U., Maggi L., Giunchedi P., La Manna A. New Oral for timing release of drugs. Boll. Chim. Farm. 131(5):1992;198-204
65. Matsuo M., Nakamura C., Arimori K., Nakano M. Evaluation for hydroxylethylcellulose as a hydrophilic swellable material for delayed-release tablets. Chem. Pharm. Bull. 43(2):1995;311-314
66. Conte U., Maggi L., Torre M.L., Giunchedi P., La Manna A. Press-coated tablets for time-programmed release of drugs. Biomaterials. 14:1993;1017-1023
67. U. Conte, A. La Manna, L. Maggi, Pharmaceutical tablets releasing the active substances after a definite period of time, U.S. patent 5, 464, 633, November 7, 1995.
68. Otsuka M., Matsuda Y. Programmable drug release of highly water-soluble pentoxifilline from drug-coated wax matrix tablets. J. Pharm. Sci. 84:1995;443-447
69. Takenchi H., Yasuji T., Yamamoto H., Kawashima Y. Spray dried lactose composite particles containing an ion complex of alginate-chitosan for designing a dry coated tablet having a time-controlled releasing function. Pharm. Res. 17:2000;94-99
70. Ishino R., Yoshino H., Hirakawa Y., Noda K. Design and preparations of pulsatile release tablet as a new oral drug delivery system. Chem. Pharm. Bull. 40:1992;3036-3041
71. Fukui E., Uemura K., Kobayashi M. Studies on applicability of press-coated tablets using hydroxypropylcelluose in the outer shell for timed-release preparation. J. Control. Release. 68:2000;215-223
72. Fukui E., Miyamura N., Kobayashi M. An in vitro investigation of the suitability of press-coated tablets with hydroxypropylmethylcellulose acetate succinate (HPMCAS) and hydrophobic additives in the outer shell for colon targeting. J. Control. Release. 70:2001;97-107
73. Lin S.-Y., Lin K.-H., Li M.-J. Micronized ethyl cellulose used for designing a directly compressed time-controlled disintegration tablet. J. Control. Release. 70:2001;321-328
74. Junginger H.L. Oral applications of pulsatile drug delvery. Gurny R., Junginger H.L., Peppas N.A. Pulsative Drug Delivery-Current Application and Future Trends. 1993;113-134 Wissenschaftliche Verlagsagesellschaft, Stuttgart
75. A.C. Shah, Therapeutic formulations with bimodal release characteristics, W.O. Patent 87/00044, January 15, 1987.
76. Shah A.C., Britten N.J., Olanoff L.S., Badalamenti J.N. Gel-matrix system exhibiting bimodal controlled-release for oral drug delivery. J. Control. Release. 9:1989;169-175
77. Sirkiä T., Mäkimartti M., Liukko-Sipe S., Marvola M. Development and biopharmaceutical evaluation of a new press-coated prolonged-release salbutamol sulfate tablet in man. Eur. J. Pharm. Sci. 1994;195-201
78. Sirkiä T., Niemi J., Marvola M., Lindqvist T., Happonen I. Effect of potassium carbonate and viscosity grade of hydroxypropylmethlcelluose on the bioavailability of furosemide from press-coated prolonged-release tablets. STP Pharma Sci. 4:1994;257-263
79. Halsas M., Simelius R., Kiviniemi A., Veski P., Jürjenson H., Marvola M. Effect of different combinations of hydroxypropylmethylcellulose an bioavailability of ibrubrofen from press-coated time-controlled tablets. STP Pharma Sci. 8:1998;155-161
80. Conte U., Maggi L. Geomatrix® tablets for the pulsatile release of drugs. Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials, Stockholm, Sweden, June 15-19. 1987;291-292
81. U. Conte, A. La Manna, L. Maggi, Controlled release tablet having lenticular from, U.S. Patent 5, 626, 874, June 6, 1997.
82. Streubel A., Jsiepmann, Peppas N.A., Bodmeier R. Bimodal drug release achieved with multi-layer matrix tablets:transport mechanisms and device design. J. Control. Release. 69:2000;455-468
83. Vinayagamkannan, Ragupathikandarapu, SanjayGarg Optimization techniquies for the design and development of novel drug delivery systems, part I. Pharm. Technol. 27(2):2003;74-90
84. Vinayagamkannan, Ragupathikandarapu, SanjayGarg Optimization techniquies for the design and development of novel drug delivery systems, part II. Pharm. Technol. 27(3):2003;102-118
85. Goutte F., Guemguem F., Dragan C., Vergnault G., Wehrle P. Power of experimental design studies for the validation of pharmaceutical process: case study of a multi-layer tablet manufacturing process. Drug Dev. Ind. Pharm. 28:2002;841-848
86. A. Shaw, Guideline on general principles of process validation, FDA, Course offered by the center for professional advancement, March 1994, OR http://www.fda.gov/cder/guidance/pv.htm (accessed Sept. 2001).
87. Davis S.S., Hardy J.G., Fara J.W. Transit of pharmaceutical dosage forms through the small intestine. Gut. 27:1986;886-892
88. Fell J.T., Newton J.M. Determination of tablets strength by the diametral-compression test. J. Pharm. Sci. 59:1970;688-691
89. Cremer K., Asmussen B. Novel Controlled-release tablet with erodible layers. Proc. Int. Control. Release Bioact. Mater. 22:1995;732-733
90. Dietrich P., Cremer K., Bauer-Brandl A., Schubert R. Complex layer tablets - aspects of a new tabletting technology. Pharm. Sci. 1(1):1998;S318
91. Dietrich P., Cremer K., Bauer-Brandl A., Schubert R. Adhesion strength in two-layer tablets. Pharm. Res. 14(11):1997;S429
92. Dietrich P., Cremer K., Bauer-Brandl A., Schubert R. Influence of particle size on adhesion in layer tablets. Proc. 2nd World Meeting APGI/APV, Paris, May 25-28. 1998;253-254
93. Heckel R.W. Density-pressure relationships in powder compaction. Trans. Metall. Soc. 221:1961;671-675
94. Dietrich P., Bauer-Brandl A., Schubert R. Influence of tableting forces and lubricant concentrations on the adhesion strength in complex layer tablets. Drug Dev. Ind. Pharm. 26(7):2000;745-754